News
Pancreatic cancer is known for its reputation of being harder to detect in its earliest stages,” said J. Bart Rose, M.D., an ...
CBS New York on MSN17d
Lustgarten Foundation's Walk For Pancreatic Cancer ResearchNineteen horses are set to race in the 2025 Kentucky Derby at Churchill Downs. Jason Franks, horse racing reporter for the Courier Journal in Kentucky, joins "The Daily Report" to discuss. Family ...
A major part of USC athletics across all sports is giving back to the community. Now, having just completed its 13th annual event, coach Eric Musselman shared t ...
10d
News-Medical.Net on MSNNew immunotherapy target found in pancreatic cancer cellsResearchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer ...
Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new study.
TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is deepening its collaboration with Oncomatryx, a biopharmaceutical company developing novel antibody-drug conjugates ...
CEO of the Lustgarten Foundation. "Their pioneering work targeting RAS-driven cancers brings real hope to the families affected by pancreatic cancer and the research community as a whole." ...
The trial aims to enroll 40 patients with FGFR alterations across the US, who won't need to travel far to receive care.
"Accelerating pancreatic cancer research is what we do and we how we make the greatest impact," added David Tuveson, MD, PhD, Chief Scientist at the Lustgarten Foundation and Cancer Center ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results